leadf
logo-loader
RNS
viewHyve Group PLC

Hyve Group PLC - Results of Rights Issue

RNS Number : 7401P
Hyve Group PLC
12 June 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA, NEW ZEALAND OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS. NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE RIGHTS ISSUE. NOTHING IN IT SHALL CONSTITUTE AN OFFERING OF ANY SECURITIES. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE  ACQUIRE,  SELL  OR  OTHERWISE  DISPOSE  OF ANY  PROVISIONAL  ALLOTMENT  LETTER,  NIL  PAID  RIGHTS, FULLY PAID RIGHTS, AND/OR NEW ORDINARY SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS. THE PROSPECTUS DATED 7 MAY 2020 IS AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.HYVE.GROUP. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

For immediate release

12 June 2020

Hyve Group plc

("Hyve" or the "Company")

 

Results of Rights Issue

The Company today announces that as at 11:00am on 11 June (being the latest time and date for receipt of valid acceptances), it had received valid acceptances in respect of 181,478,513 New Ordinary Shares, representing approximately 98.87 per cent. of the total number of New Ordinary Shares offered pursuant to the 9 for 4 rights issue announced by the Company on 7 May 2020 (the "Rights Issue"), details of which were set out in the Prospectus dated 7 May 2020.

It is expected that dealings in the New Ordinary Shares, fully paid, will commence on the London Stock Exchange's main market for listed securities from 8:00 am on 12 June.

It is also expected that the Rights Issue Shares held in uncertificated form will be credited to CREST accounts as soon as practicable after 8:00am on 12 June, and that definitive share certificates in respect of New Ordinary Shares held in certificated form will be dispatched by no later than 26 June to Qualifying Non-CREST Shareholders who have taken up their Rights.

In accordance with their obligations as underwriters and subject to the terms and conditions of the underwriting agreement dated 7 May 2020 between the Company and Numis, HSBC and Barclays (the "Underwriters"), the Underwriters shall severally and not jointly (or jointly and severally) and as agents for the Company, use their reasonable endeavours to procure subscribers for the remaining 2,071,568 New Ordinary Shares not validly taken up in the Rights Issue, failing which the Underwriters have agreed to acquire, in proportion to their underwriting commitment, any remaining New Ordinary Shares.

The net proceeds from the placing of such New Ordinary Shares (being the amount paid by such subscribers after deducting the Issue Price of 69 pence per New Ordinary Share and the expenses of procuring such subscribers including any applicable commissions and any related irrecoverable VAT), if any, will be paid (without interest) to those persons whose rights have lapsed in accordance with the terms of the Rights Issue, pro rata to their lapsed provisional allotments, save that no payment will be made of amounts of less than £5.00, which amounts will be aggregated and ultimately paid to the Company for its own benefit.

A further announcement as to the number of unaccepted New Ordinary Shares for which subscribers have been procured will be made in due course.

For further information, please contact:

 

Hyve Group plc

+44 (0)20 3545 9400

Mark Shashoua / Andrew Beach




Numis (Sponsor, Financial Adviser, Corporate Broker, Joint Global Coordinator, Joint Bookrunner & Joint Underwriter)

+44 (0)20 7260 1000

Nick Westlake / Matt Lewis / Hugo Rubinstein / William Baunton




Barclays (Joint Global Coordinator, Joint Bookrunner & Joint Underwriter)

+44 (0)20 7623 2323

Alastair Blackman / Lawrence Jamieson / Ben West / Kunal Bidani




HSBC (Joint Global Coordinator, Joint Bookrunner & Joint Underwriter)

+44 (0)20 7991 8888

Andrea Coda / Sam Hart / Bhavin Dixit /Jonathan Surr




FTI Consulting

+44 (0)20 3727 1000

Charles Palmer / Emma Hall / Chris Birt


 

 

IMPORTANT NOTICE 

This announcement has been issued by and is the sole responsibility of the Company. The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may or should be placed by any person for any purpose whatsoever on the  information  contained  in  this  announcement  or  on  its  accuracy  or completeness. The information in this announcement is subject to change.

This announcement is an advertisement and not a prospectus and not an offer of Nil Paid Rights, Fully Paid Rights or New Ordinary Shares for sale in any jurisdiction, including in or into the United States, Australia, Canada, Japan, South Africa, New Zealand and any other jurisdiction where the extension or availability of the Rights Issue (and any other transaction contemplated thereby) would breach any applicable law (each an "Excluded Territory").

Neither this announcement nor anything contained in it shall form the basis of,  or  be  relied  upon  in  connection  with,  any  offer  or  commitment whatsoever  in  any  jurisdiction.  Investors should not acquire any Nil Paid

Rights,  Fully  Paid  Rights  or  New  Ordinary  Shares  referred  to  in  this announcement  except  on  the  basis  of  the  information  contained  in  the Prospectus to be published by the Company in connection with the Rights Issue.

 

The Prospectus dated 7 May 2020 is available on the Company's website at www.hyve.group. Neither the content of the  Company's  website  nor  any  website  accessible  by  hyperlinks  on  the Company's website is incorporated in, or forms part of, this announcement.

 

The  distribution  of  this  announcement,  the  Prospectus,  any other offering or public material relating to the Rights Issue and/or the Provisional Allotment Letter and/or the transfer of Nil Paid Rights, Fully Paid Rights and/or New Ordinary Shares through CREST or otherwise into a jurisdiction other than the United Kingdom may be restricted by law and therefore persons outside of the United Kingdom into whose possession this announcement and/or any accompanying documents come should inform themselves about and observe any such restrictions. In particular, subject to certain exceptions, this announcement and the accompanying documents should not be distributed, forwarded to or transmitted in or into the United States or any of the other Excluded Territories.

Recipients of this announcement and/or the Prospectus should conduct their own investigation, evaluation and analysis of the business, data and property described in this announcement and/or the Prospectus. This announcement does not constitute a recommendation concerning any investor's options with respect to the Rights Issue. The price and value of securities can go down as well as up. Past performance is not a guide to future performance. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each Shareholder or prospective investor should consult his, her or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 

This announcement is not and does not contain an offer of securities for sale or a solicitation of an offer to purchase or subscribe for securities in the United States or any other Excluded Territory, or any other state or jurisdiction in which such release, publication or distribution would be unlawful. The securities to which this announcement relates (the "Securities") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "US Securities Act"), or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the Securities in the United States. Subject to certain exceptions, the Securities may not be offered or sold in any other Excluded Territory or to, or for the account or benefit of, any national, resident or citizen of such countries.

 

Accordingly, subject to certain exceptions, the Rights Issue is not being made in the United States and neither this announcement, the Prospectus nor the Provisional Allotment Letters constitute or will constitute an offer, or an invitation to apply for, or an offer or an invitation to subscribe for or acquire any Nil Paid Rights, Fully Paid Rights or New Ordinary Shares in the United States. Subject to certain limited exceptions, Provisional Allotment Letters have not been, and will not be, sent to, and Nil Paid Rights have not been, and will not be, credited to the CREST account of, any Qualifying Shareholder with a registered address in or that is located in the United States.

 

The information in this announcement may not be forwarded or distributed to any other person and may not be reproduced in any manner whatsoever. This announcement should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations, including but not limited to (subject to certain exceptions) the United States and any of the other Excluded Territories.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of these securities (subject to certain exceptions), in Canada.  In Canada, no prospectus has been filed with any securities commission or similar regulatory authority in respect of the Securities. No such securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the merits of any proposed offering of the Securities and any representation to the contrary is an offence.

In Canada. the Securities may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or, in Ontario, subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the Securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.

Each of Numis, which is authorised and regulated in the United Kingdom by the FCA, and HSBC and Barclays which are authorised by the Prudential  Regulation  Authority  (PRA)  and  regulated  in  the  United Kingdom  by  the  PRA  and  FCA, are acting exclusively for the Company and no one else in connection with the Rights Issue and will not regard anyone (whether or not a recipient of this announcement) other than the Company as their respective clients in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients nor for providing advice in connection with the Rights Issue, or any other matter referred to in this announcement.

 

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or their respective affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other information made available to or  publicly available to any interested party or its advisers, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available, and any liability therefore is expressly disclaimed.

In connection with the Rights Issue, the Joint Bookrunners and any of their affiliates, may in accordance with applicable legal and regulatory provisions, engage in transactions in relation to the Nil Paid Rights, the Fully Paid Rights, the New Ordinary Shares and/or related instruments for their own account for the purpose of hedging their underwriting exposure or otherwise. Accordingly, references in the Prospectus to the Nil Paid Rights, Fully Paid Rights or New Ordinary Shares being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or  dealing by Numis, HSBC and Barclays and any of their affiliates acting in such capacity.

 

The Joint Bookrunners and any of their affiliates may enter into financing arrangements with investors in connection with which the Joint Bookrunners and any of their affiliates may from time to time acquire, hold or dispose of Ordinary Shares. The Joint Bookrunners do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

Further to any contractual obligations that may be in place between the Joint Bookrunners, the Joint Bookrunners and their respective affiliates may, in compliance with applicable law or regulation, for a limited period coordinate further sales of New Ordinary Shares following the transaction.  Except as required by applicable law or regulation, the Joint Bookrunners and their respective affiliates do not propose to make any public disclosure in relation to such transactions.

INFORMATION TO DISTRIBUTORS

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Nil Paid Rights, the Fully Paid Rights and the New Ordinary Shares have been subject to a product approval process, which has determined that they each are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment"). Notwithstanding the Target Market Assessment, Distributors should note that: the price of the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares may decline and investors could lose all or part of their investment; the New Ordinary Shares offer no guaranteed income and no capital protection; and an investment in the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offer. Furthermore, it is noted that, notwithstanding the Target Market Assessment, the Joint Bookrunners will only procure investors who meet the criteria of professional clients and eligible counterparties. For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Nil Paid Rights, the Fully Paid Rights and/or the New Ordinary Shares and determining appropriate distribution channels.

Forward-looking statements

Nothing in this announcement is, or should be relied on as, a promise or representation as to the future.  Certain information contained in this announcement constitutes "forwardlooking statements", which can be identified by the use of terms such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue," "target" or "believe" (or the negatives thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or actual performance of the Company may differ materially from any opinions, forecasts or estimates reflected or contemplated in this announcement. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or estimates. Investors should not rely on such forwardlooking statements in making their investment decisions. No representation or warranty is made as to the achievement or reasonableness of and no reliance should be placed on such forwardlooking statements. The past performance of the Company is not a reliable indication of the future performance of the Company. No statement in this announcement is intended to be nor may it be construed as a profit forecast. Any investment in the Company is speculative, involves a high degree of risk, and could result in the loss of all or substantially all of their investment. Results can be positively or negatively affected by market conditions beyond the control of the Company or any other person.

Neither the Company, Numis, HSBC, Barclays or their affiliates or their respective representatives are under any obligation to keep current the information contained in this announcement.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ROIMZGMVGMGGGZZ

Quick facts: Hyve Group PLC

Price: -

Market: LSE
Market Cap: -
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

16 min read